EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.7.8.11 | 1-stearoyl-2-arachidonoylphosphatidylinositol + CMP |
- |
Mus musculus |
CDP-1-stearoyl-2-arachidonoylglycerol + myo-inositol |
- |
r |
2.7.8.11 | 2-deoxy-CDP-diacylglycerol + myo-inositol |
- |
Homo sapiens |
CMP + ? |
- |
r |
2.7.8.11 | 2-deoxy-CDP-diacylglycerol + myo-inositol |
optimal activity is 25% higher then with CDP-diacylglycerol |
Homo sapiens |
CMP + ? |
- |
r |
2.7.8.11 | 2-deoxy-CDP-diacylglycerol + myo-inositol |
maximal activity only 36% of the optimal activity reached with CDP-diacylglycerol |
Candida albicans |
CMP + ? |
- |
r |
2.7.8.11 | CDP-1-arachidonoyl-2-stearoylglycerol + myo-inositol |
6% of the activity with CDP-1-stearoyl-2-oleoylglycerol |
Cavia porcellus |
CMP + 1-arachidonoyl-2-stearoylphosphtidylinositol |
- |
r |
2.7.8.11 | CDP-1-stearoyl-2-arachidonoylglycerol + myo-inositol |
4% of the activity with CDP-1-stearoyl-2-oleoylglycerol |
Cavia porcellus |
CMP + 1-stearoyl-2-arachidonoylphosphatidylinositol |
- |
r |
2.7.8.11 | CDP-1-stearoyl-2-oleoylglycerol + myo-inositol |
- |
Cavia porcellus |
CMP + 1-stearoyl-2-oleoylphosphatidylinositol |
- |
r |
2.7.8.11 | CDP-diacylglycerol + 1D-chiro-inositol |
conversion of 30.9% CDP-diacylglycerol (utilization significant compared to background, p: 0.05), microsomal fraction, 30°C, 20 min |
Tetrahymena vorax |
CMP + phosphatidyl-1D-chiro-inositol |
- |
? |
2.7.8.11 | CDP-diacylglycerol + 1L-chiro-inositol |
conversion of 25.1% CDP-diacylglycerol (non-significant), microsomal fraction, 30°C, 20 min |
Tetrahymena vorax |
CMP + phosphatidyl-1L-chiro-inositol |
- |
? |
2.7.8.11 | CDP-diacylglycerol + allo-inositol |
83% of the activity on myo-inositol |
Tetrahymena vorax |
CMP + phosphatidyl-allo-inositol |
- |
? |